Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA3165 GGTI298Summary: GGTI298 is a potent GGTaseI inhibitor. -
BA3166 Thalidomide-O-amido-C3-PEG3-C1-NH2Summary: Thalidomide-O-amido-C3-PEG3-C1-NH2 is a synthetic E3 ligase ligand-linker coupler. -
BA3167 CMLD010509Summary: CMLD010509 (SDS-1-021) is a highly specific inhibitor that supports the oncogenic translational program in multiple myeloma (MM). -
BA3168 NevanimibeSummary: Nevanimibe (PD-132301) is an orally effective, selective acyl coenzyme A:cholesterol O-acyltransferase 1 inhibitor. -
BA3169 S2116Summary: S2116, an N-alkylated trans-cyclopropylamine (TCP) derivative, is a potent lysine-specific demethylase 1 inhibitor. -
BA3170 CantrixilSummary: Cantrixil (TRX-E-002-1) is the active enantiomer of TRX-E-002, a second generation superbenzopyran (SBP) compound. -
BA3171 S2157Summary: S2157, an N-alkylated trans-cyclopropylamine (TCP) derivative, is a potent lysine-specific demethylase 1 inhibitor. -
BA3172 Thalidomide-piperazine-BocSummary: An intermediate that can be used in the synthesis of BCL6. -
BA3173 Thalidomide-NH-PEG4-COOHSummary: Thalidomide-NH-PEG4-COOH is an E3 ligase ligand-linker coupler that can be used to synthesize dCBP-1. -
BA3174 RIPGBMSummary: RIPGBM is a selective apoptosis inducer that induces apoptosis in glioblastoma multiforme (GBM) cancer stem cells (CSCs).

